NASDAQ:CRMD
CorMedix Inc. (CRMD)
Financials 
Technical Analysis 
Jul 6, 2026, 12:00 amThis summary was created by AI, based on 2 opinions in the last 12 months.
CorMedix Inc. (CRMD) has been under scrutiny by analysts, with recent reviews reflecting a somewhat cautious stance on the stock. Michael O'Reilly from Stockchase highlights that CRMD has triggered a stop loss at $9.50, indicating concerns about its recent performance, which has seen a drop of 25.7%. However, he also notes the positive momentum stemming from the company's antimicrobial catheter lock product, praised for its clinical efficacy in reducing infections by over 70%, which translates to significant cost savings for health plans. With the stock trading at a Price-to-Earnings ratio of 17x and a strong return on equity of 38%, there are still optimistic projections for the stock, with an average price target of $19.50 and an indicated upside potential of 28%. Investors are advised to monitor market conditions closely, especially given the support and resistance levels highlighted in the reviews.
;fill-opacity:1;'/%3e%3cpath%20d='M31%2018.6001V30H8V18.6001L14.1334%2022.4334L19.4999%2014L24.8669%2022.4334L31%2018.6001Z'%20fill='%23EE5432'%20style='fill:%23EE5432;fill:color(display-p3%200.9340%200.3310%200.1956);fill-opacity:1;'/%3e%3c/svg%3e){kind=small}
Premium content
Premium contentCRMD is beginning to see fruit of its antimicrobial catheter lock -- the first and only in the heath space introduced in last year -- that has been clinically proven to reduce infection by over 70% (a BIG cost saver to health plans). It trades at 17x earnings, 4x book and supports a robust 38% ROE. We recommend setting a stop-loss at $9.50, looking to achieve $17.00 -- upside potential of 28%. Yield 0%
(Analysts’ price target is $19.50)- «
- ‹
- 1
- ›
- »
Popular Articles
Most Recent Experts
CorMedix Inc. (CRMD) Frequently Asked Questions
What is CorMedix Inc. stock symbol?
CorMedix Inc. is a American stock, trading under the symbol CRMD (previously CRMD-Q on Stockchase) on the NASDAQ (CRMD). It is usually referred to as NASDAQ:CRMD or CRMD
Is CorMedix Inc. a buy or a sell?
In the last year, 2 stock analysts issued a Buy, Sell, or Hold rating on CRMD (previously CRMD-Q on Stockchase). 2 analysts recommended to BUY and 0 analysts recommended to SELL the stock. The latest stock analyst rating is TOP PICK. Read the latest stock experts' ratings for CorMedix Inc..
Is CorMedix Inc. a good investment or a top pick?
CorMedix Inc. was recommended as a Top Pick by The Panic-Proof Portfolio (Stockchase Research) on 2025-09-04. Read the latest stock experts ratings for CorMedix Inc..
Why is CorMedix Inc. stock dropping?
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for CorMedix Inc..
Is CorMedix Inc. worth watching?
CorMedix Inc. is covered by Stockchase experts and is worth watching.
What is CorMedix Inc. stock price?
On 2026-07-02, CorMedix Inc. (CRMD) stock closed at a price of $8.74.
Our PAST TOP PICK with CRMD has triggered its stop at $9.50. To remain disciplined, we recommend covering the position at this time.